Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bristol Monopril market share tops 20% at Omnicare-affiliated nursing homes.

Executive Summary

BRISTOL MONOPRIL MARKET SHARE IS OVER 20% AT OMNICARE-AFFILIATED nursing homes within one year of being named a preferred ACE inhibitor on Omnicare's "Geriatric Pharmaceutical Care Guidelines," Omnicare said. Monopril's market share climbed from 2% in December 1994 to 20% at the end of 1995 and has gone even higher in early 1996, Omnicare said. Bristol-Myers Squibb highlights Monopril's performance in the Omnicare system in its recently released annual report.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS027978

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel